4th Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for GILEAD SCIENCES INC

Period 4th Quarter 2022 Filed Jan 20, 2023 Signed by Brian Pomper

Official filing
Firm
AKIN GUMP STRAUSS HAUER & FELD
Client
GILEAD SCIENCES INC
Income
$10,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.; general healthcare issues.

LobbyistCovered position, as disclosed
LOUIS AGNELLO —
VIRGIL MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3506 (117th)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.; Issues related to waiver of intellectual property rights for COVID therapeutics and diagnostics.

LobbyistCovered position, as disclosed
STEPHEN KHO —
BRIAN ARTHUR POMPER —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Natl Security Council (NSC); SENATE

Bills named: S. 3506 (117th)

Copyright/Patent/Trademark CPT

Issues related to waiver of intellectual property rights for COVID therapeutics and diagnostics.

LobbyistCovered position, as disclosed
STEPHEN KHO —
BRIAN ARTHUR POMPER —

Contacted: SENATE; U.S. Trade Representative (USTR); Natl Security Council (NSC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.